Skip to content

Clinical trials

Expanded access trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Malaysia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing6
No longer available3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bayer1
Eisai Inc.1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis1
Novartis Pharmaceuticals1
Pfizer1
Tibotec Pharmaceuticals, Ireland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Genital Diseases, Male1
Genital Neoplasms, Male1
HIV Infections1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
Neoplasm Metastasis1
Neoplasms1
Prostatic Neoplasms1

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.